Drug cuts risk of allergic reactions to peanuts and other foods
Researchers showed that a drug used to treat allergic asthma can reduce reactions to peanuts and other common foods in children with multiple food allergies. (Source: NIH Research Matters from the National Institutes of Health (NIH))
Source: NIH Research Matters from the National Institutes of Health (NIH) - March 5, 2024 Category: Consumer Health News Source Type: news
Xolair a New Weapon Against Food Allergies, but Questions Remain
An old drug offers new tricks for people with multiple food allergies, but costs and access issues could limit its use. (Source: WebMD Health)
Source: WebMD Health - March 4, 2024 Category: Consumer Health News Source Type: news
AAAAI 2024: Insights on Advancements in Food Allergy Management AAAAI 2024: Insights on Advancements in Food Allergy Management
Dr David A. Hill shares highlights from AAAAI 2024, including the new indication for omalizumab and fresh data on oral immunotherapy.Medscape (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - March 1, 2024 Category: Consumer Health News Tags: Allergy & Clinical Immunology MDAngle Source Type: news
Doctor's Family Sues Disney Over Food Allergy Death; Doctor Skipped Payroll Taxes?
(MedPage Today) -- The family of New York doctor Kanokporn Tangsuan, DO, is suing Disney following her death, allegedly from eating a meal that wasn't allergen-free. Tangsuan was highly allergic to nuts and dairy and reportedly died from anaphylaxis... (Source: MedPage Today Public Health)
Source: MedPage Today Public Health - February 29, 2024 Category: American Health Source Type: news
Omalizumab for Food Allergies: What PCPs Should Know Omalizumab for Food Allergies: What PCPs Should Know
With omalizumab recently approved to treat multiple food allergies, allergist-immunologists advised PCPs on how they can use the drug in practice.Medscape Medical News (Source: Medscape Allergy Headlines)
Source: Medscape Allergy Headlines - February 29, 2024 Category: Allergy & Immunology Tags: Internal Medicine Source Type: news
FDA Approves Omalizumab for Multiple Food Allergy FDA Approves Omalizumab for Multiple Food Allergy
Omalizumab reduced the incidence of allergic reactions to multiple food items in a double-blind trial.Medscape Medical News (Source: Medscape Allergy Headlines)
Source: Medscape Allergy Headlines - February 29, 2024 Category: Allergy & Immunology Tags: Emergency Medicine Source Type: news
AAAAI: Omalizumab Superior to Placebo for Those With Multiple Food Allergies
MONDAY, Feb. 26, 2024 -- Omalizumab treatment for 16 weeks is superior to placebo for increasing the reaction threshold for peanut and other food allergens among persons with multiple food allergies, according to a study published online Feb. 25 in... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - February 26, 2024 Category: Pharmaceuticals Source Type: news
Asthma Drug Xolair Guards Against Severe Reactions in People With Food Allergies
MONDAY, Feb. 26, 2024 -- The asthma medication Xolair has proved its prowess against food allergies, with new research showing the medication substantially lowers the chances of severe reactions in patients.Data published Sunday... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - February 26, 2024 Category: General Medicine Source Type: news
New England Journal of Medicine publishes Phase III data showing Xolair significantly reduced allergic reactions across multiple foods in people with food allergies
Detailed results from the NIH-sponsored Phase III OUtMATCH study showed treatment with Xolair increased the amount of peanuts, tree nuts, egg, milk and wheat that people as young as 1 year consumed without an allergic reactionThe U.S. FDA recently approved Xolair as the first and only medicine for children and adults with one or more food allergiesAllergic reactions can be life-threatening and it is estimated that food-related anaphylaxis results in 30,000 medical events treated in emergency rooms in the U.S. each year1-3Basel, 25 February 2024 - Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today data from Stage 1 of the N...
Source: Roche Investor Update - February 25, 2024 Category: Pharmaceuticals Source Type: news
New England Journal of Medicine publishes Phase III data showing Xolair significantly reduced allergic reactions across multiple foods in people with food allergies
Detailed results from the NIH-sponsored Phase III OUtMATCH study showed treatment with Xolair increased the amount of peanuts, tree nuts, egg, milk and wheat that people as young as 1 year consumed without an allergic reactionThe U.S. FDA recently approved Xolair as the first and only medicine for children and adults with one or more food allergiesAllergic reactions can be life-threatening and it is estimated that food-related anaphylaxis results in 30,000 medical events treated in emergency rooms in the U.S. each year1-3Basel, 25 February 2024 - Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today data from Stage 1 of the N...
Source: Roche Media News - February 25, 2024 Category: Pharmaceuticals Source Type: news
Omalizumab Increases the Reaction Threshold for Peanut and Other Common Food Allergies
Study highlights a valuable option for safe and effective food allergy treatment. WASHINGTON, Feb. 25, 2024 /PRNewswire-PRWeb/ -- Sixteen weeks of omalizumab results in a higher tolerated threshold for multiple food allergies according to new research presented today at the 2024 American... (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - February 25, 2024 Category: Pharmaceuticals Tags: TRI SVY Source Type: news
Xolair for food allergies: How it works and what it costs
Kevin Wang and Annie Marqueling’s son Liam was 8 months old when he broke out in hives all over his body after eating a few bits of a scrambled egg. An allergy test revealed Liam was allergic to eggs, as well as peanuts and tree nuts, and for the next year, the entire family avoided foods that…#kevinwang #anniemarquelings #wang #paloalto #xolair #sharonchinthrajah #stanforduniversity #chinthrajah #fda #annalsofallergy (Source: Reuters: Health)
Source: Reuters: Health - February 25, 2024 Category: Consumer Health News Source Type: news
Roche's Xolair reduces reactions to severe food allergies in study
(Source: Reuters: Health)
Source: Reuters: Health - February 25, 2024 Category: Consumer Health News Source Type: news
What to Know About Xolair and Food Allergies
The drug does not completely prevent reactions, but it can reduce the risks posed by trace amounts of food allergens. (Source: NYT Health)
Source: NYT Health - February 25, 2024 Category: Consumer Health News Authors: Roni Caryn Rabin Tags: your-feed-science Allergies Food Children and Childhood Drugs (Pharmaceuticals) Immune System Clinical Trials Research Health Insurance and Managed Care Source Type: news
An Asthma Drug Can Drastically Reduce Food Allergies
About 20 million people in the U.S.—including four million children—have food allergies. Now, there’s a new way to reduce their risk of severe allergic reactions. A study published in the New England Journal of Medicine reports that the drug omalizumab, or Xolair, allows people with food allergies to tolerate higher doses of allergenic foods before developing a reaction after an accidental exposure. It also leads to milder reactions if they are exposed.
[time-brightcove not-tgx=”true”]
The drug was originally approved more than two decades ago to treat allergic asthma. But because of this ...
Source: TIME: Health - February 25, 2024 Category: Consumer Health News Authors: Alice Park Tags: Uncategorized healthscienceclimate Source Type: news
